Tim McClure, MD

Attending Physician
Weill Cornell Medicine

Presentation(s):

• Safety and Efficacy of Percutaneous Cholangioscopy-Assisted Rigid ShockPulse Lithotripsy for Inoperable Calculous Cholecystitis: A Multi-Instuitional Prospective Review

  Sunday, March 5, 2023
  4:21 PM – 4:30 PM

  Disclosure(s): boston scientific: Advisory Committee or Review Panel Member (Ongoing); Johnson & Johnson: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing)

• Microwave Ablation versus Cryoablation for T1a Renal Cell Carcinoma: A Systematic Literature Review and Meta-Analysis

  Monday, March 6, 2023
  12:00 PM – 1:00 PM

  Disclosure(s): boston scientific: Advisory Committee or Review Panel Member (Ongoing); Johnson & Johnson: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing)

• Multi-institutional Prospective Analysis of Percutaneous Image-Guided Large Bore Gallstone Extraction for Inoperable Acute Calculous Cholecystitis

  Monday, March 6, 2023
  12:00 PM – 1:00 PM

  Disclosure(s): boston scientific: Advisory Committee or Review Panel Member (Ongoing); Johnson & Johnson: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing)

• Cone Beam CT with Dedicated Planning Software Improves Optimal Gantry Angle Selection for Prostate Artery Embolization

  Monday, March 6, 2023
  3:18 PM – 3:27 PM

  Disclosure(s): boston scientific: Advisory Committee or Review Panel Member (Ongoing); Johnson & Johnson: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing)

• Radiation Dose Reduction in Prostate Artery Embolization Using Advanced Imaging Guidance

  Monday, March 6, 2023
  5:05 PM – 5:10 PM

  Disclosure(s): boston scientific: Advisory Committee or Review Panel Member (Ongoing); Johnson & Johnson: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing)

• Stone Management: Urologists only?

  Tuesday, March 7, 2023
  1:54 PM – 2:07 PM

  Disclosure(s): boston scientific: Advisory Committee or Review Panel Member (Ongoing); Johnson & Johnson: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing)

• Current data on Prostate Embolization (and why AUA still considers it experimental?)

  Tuesday, March 7, 2023
  3:14 PM – 3:28 PM

  Disclosure(s): boston scientific: Advisory Committee or Review Panel Member (Ongoing); Johnson & Johnson: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing)